PHOSPHOLIPID COMPLEXES OF PROANTOCYANIDINE A2 AS ANTIATHEROSCLEROTIC AGENTS

FIELD: medicine. ^ SUBSTANCE: the present innovation deals with phospholipid complexes of proanthocyanidine A2 and pharmaceutical compositions upon their basis as antiatherosclerotic agents, those for preventing and treating myocardial and cerebral infarction. Phospholipids of the above-mentioned complex should be preferably chosen out of lecithins, phosphatidyl choline, phosphatidyl ethanolamine, phosphatidyl serine. The innovation provides the preparation to treat the above-mentioned diseases due to decreasing the quantity and burden of atheromatous plaque, decreased obstruction of carotid arteries and decreased thickness of vascular walls. ^ EFFECT: higher efficiency of prophylaxis and therapy. ^ 9 cl, 11 dwg, 6 ex, 2 tbl